MedTrace Logo

Transdermal Ketoprofen to Treat Mild to Moderate Osteoarthritis (OA) Pain of the Knee

NCT00108810 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2012-06-05

No results posted yet for this study

Summary

The purpose of the study is to evaluate the safety and effectiveness of the investigational ketoprofen patch with a controlled heating patch, compared to placebo (inactive substance) for the treatment of pain caused by osteoarthritis.

Conditions

  • Pain
  • Osteoarthritis, Knee

Interventions

DRUG

Transdermal Ketoprofen Patch with CHADD

12 hours patch application for 28 days

DRUG

Placebo transdermal patch

12 hours application for 28 days

Sponsors & Collaborators

  • ZARS Pharma Inc.

    lead INDUSTRY

Principal Investigators

  • David Borenstein, MD · The Center for Rheumatology

  • H F Farmer, MD · Radiant Research Inc.

  • Larry Gilderman, DO · University Clinical Research

  • Soledad Lee, MD · Southbay Pharma Research

  • Joseph A Markenson, MD · Hospital for Special Surgery, New York

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2005-10-31
Completion
2005-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00108810 on ClinicalTrials.gov